Journal of Pharmaceutical Investigation

The Korean Society of Pharmaceutical Sciences and Technology (한국약제학회)
권호 표지
DOI QR코드

DOI QR Code

The Effect of Enhancers on the Penetration of Clenbuterol through Hairless Mouse Skin

클렌부테롤의 피부투과에 미치는 경피흡수촉진제의 영향

  • Published : 2003.03.20
Download PDF
⟨ Previous Next ⟩

Abstract

Clenbuterol, a selective ${\beta}_2-adrenergic$ receptor stimulant, has been introduced as a potent bronchodilator for patients with bronchial asthma, chronic obstructive bronchial disease, chronic bronchitis and pulmonary emphysema. The percutaneous permeation of clenbuterol was investigated in hairless mouse skin after application of 50/50 buffer(pH 10)/propylene glycol solvent mixture. The enhancing effects of various penetration enhancers such as terpenes, non-ionic surfactants, pyrrolidones, fatty acids and some other enhancers on the permeation of clenbuterol were evaluated using Franz diffusion cell. Among terpenes studied, 1,8-cineole was the most effective enhancer, which increased the permeability of clenbuterol approximately 39.33-fold compared with the control without penetration enhancer, followed by menthone with enhancement ratio of 23.57. Nonionic surfactants did not have significant enhancing effects. N-Lauryl-2-pyrrolidone increased the permeability of clenbuterol approximately 4.51-fold compared with the control. Lauric acid increased the permeability of clenbuterol approximately 35.57-fold with decreasing the lag time from 2.64 to 0.52 hr. Oleic acid, linoleic acid, linolenic acid and capric acid showed enhancement ratio of 22.62, 19.60, 17.45 and 16.51, respectively. $Labrafil^{\circledR}$ enhanced the permeability of clenbuterol 9.24-fold compared with that without enhancer.

Keywords

References

  1. J.M. Hadgraft, Transdermal drug delivery, Marcel Dekker,New York, U.S.A. (1989)
  2. C.T. O.Neil and P.B. Deasy, Development and evaluatio nusing hairless mouse skin of a traasdermal product, Int. J.Pharm., 48, 247-254 (1988) https://doi.org/10.1016/0378-5173(88)90269-4
  3. Y.W. Chien, Novel Drug Delivery System, Marcel Dekker,New York, U.S.A. (1992)
  4. C. Pasotti, A. Capra and C. Vibelli, NAB 365 (clenbuterol) and salbutamol in asthmatics: a double-blind clinical trial, Int. J. Ctin. Pharmcol. Biopharm., 17, 176-180 (1979)
  5. Von Z, Kopitar and A. Zimmer, Vergleich des pharmaco-kinetischen Profils von Clenbuterol bei Ratte und Hund w hrend toxikologischer Untersuchungen, Arzneim-Forsch, 26, 1450-1455 (1976)
  6. Y. Itaru, I. Kohji. and N. Mitsuyoshi, Pharmacokinetics of plasma and urine clenbuterol in man, rat, and rabbit, J.Pharmacobio-Dyn., 8, 385-391 (1985) https://doi.org/10.1248/bpb1978.8.385
  7. F. Masaki, K. Yumie, H. Takuma and M. Tamotsu, Coughreceptor sensitivity and bronchial responsiveness in patientswith only chronic nonproductive cough: In view of effect of bronchodilator therapy, J. Asthma, 31, 463-472 (1994) https://doi.org/10.3109/02770909409089488
  8. R.J. Scheuplein, Skin as a barrier : In The Physiology and Pathophysiology of Skin. Vol. 5, A. Jarret (Ed.), Academic Press, New York, U.S.A., PP. 1693-1730 (1978)
  9. E.R. Cooper, E.W. Merrit and R.L. Smith, Effect of fattyacids and alcohols on the penetration of acyclovir across human skin in vitro, J. Pharm. Sci., 74, 688-689 (1985) https://doi.org/10.1002/jps.2600740623
  10. J. Yukawa, K. Sugibayashi and Y. Morimoto, Effect of variousadditives on the skin permeation of ketoprofen from the film forming transdermal formulation, Yakuzaigaku, 49, 254-262 (1989)
  11. D.J. Chatterjee, W.Y. Li and R.T. Koda, Effect of vehicles andpenetration enhancers on the in vitro and in vivo percutaneous absorption of methotrexate and edatrexate through hairlessmouse skin, Pharm. Res., 14, 1058-1065 (1997) https://doi.org/10.1023/A:1012109513643
  12. B.J. Aungst, N.J. Rogers and E. Shefter, Enhancement of naloxone penetration through human skin in vitro using fattyacids, fatty alcohols, surfactant, sulfoxides and amides, Int. J.Pharm., 33, 225-234 (1986) https://doi.org/10.1016/0378-5173(86)90057-8
  13. D.D. Kim and Y.W. Chien, Transdermal delivery of dideoxy-neucleoside-type anti-HIV drugs. 2. The effect of vehicle and enhancers on skin permeation, J. Pharm. Sci., 85, 214-219(1996) https://doi.org/10.1021/js950141c
  14. R.S. Hinz, C.D. Hodsoa, C.R. Lorence and R.H. Guy, In vitropercutaneous penetration: evaluation of the utility of hairless mouse skin, J. Invest. Dermatol., 93, 87-91 (1989) https://doi.org/10.1111/1523-1747.ep12277361
  15. Y.D. Lee, Q.Z. Quan, S.Y. Jung, J.D. Rhee and C.S. Yong, The effect of fatty acids, fatty alcohols and propylene glycol on the penetration of clenbuterol through hairless mouse skin, J. Kor.Pharm. Sci., 29, 329-335 (1999)
  16. M.H.A. Botterblom, M.G.P. Feenstra and E.B.H.W. Erdtsieck-Emste, Detennmation of propranolol, labetalol and clenbuterolin rat brain by high-performance liquid chromatography, J.Chromatogrphy., 613, 121-126 (1993) https://doi.org/10.1016/0378-4347(93)80204-H
  17. T.K. Ghosh, W.R. Pfister and S.I. Yum, Transdermal and Topical Drug Dehvery Systems, Inteipharm Press, BuffaloGrove, IL, U.S.A. (1997)
  18. A.C. Williams and B.W. Bany, Essential oils as novel human skin penetration enhancers, Int. J. Pharm., 57, R7-R9 (1989) https://doi.org/10.1016/0378-5173(89)90310-4
  19. D. Monti, P. Chetoni, S. Burgalassi, M. Najarro, M. Fabrizio Saettone and E. Boldini, Effect of different terpene-containing essential oils on permeation of estradiol through hairlessmouse skin, Int. J. Pharm., 237, 209-214 (2002) https://doi.org/10.1016/S0378-5173(02)00032-7
  20. A.K-. Jain, N.S. Thomas and R. Panchagnula, Transdermal drug delivery of imipramine hydrochloride.: I. Effect of terpenes, J. Control. Rel., 79, 93-101 (2002) https://doi.org/10.1016/S0168-3659(01)00524-7
  21. B. M. Magnusson, P. Runn, K. Karlsson and L. -O. D.Koskinen, Terpenes and ethanol enhance the transdermal permeation of the tripeptide thyrotropin releasing hormone in human epidermis, Int. J. Pharm., 157, 113-121 (1997) https://doi.org/10.1016/S0378-5173(97)00235-4
  22. B.W. Barry, Lipid-Protein-Partitioning theory of skin penetration enhancement, J. Control. ReL, 15, 237-248 (1987)
  23. P.A. Cornwell and B.W. Barry, Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil, J. Pharm. Pharmacol, 46, 261-269 (1994) https://doi.org/10.1111/j.2042-7158.1994.tb03791.x
  24. A.C. Williams and B.W. Barry, Transdermal oestradiol permeation: the effects of terpene penetration enhancers, In: Prediction of Percutaneous Penetration: Methods, Measurements, Modelling, R.C. Scott, R.H. Guy, J. Hadgraft and H.E. Bodde(Eds), IBC Technical Services, London, PP. 386-393 (1991)
  25. A.C. Williams and B.W. Barry, Terpenes and the lipid-protein partitioning theory of skin penetration enhancement, Pharm.Res., 8, 17-24 (1991) https://doi.org/10.1023/A:1015813803205
  26. H. Okabe, Y. Obata, K. Takayama, and T. Nagai, Percutaneous absorption enhancing effect and skin irritation of monocyclic monoterpenes. Drug Des. Detliv., 6, 229-238 (1990)
  27. Y. Obata, K. Takayama, Y. Maitani, Y. Machida and T. Nagai, Effect of pretreatment of skin with cyclic monoterpenes on permeation of diclofenac in hairless rat, Biol, Pharm. Bull., 16, 312-314 (1993) https://doi.org/10.1248/bpb.16.312
  28. J. Shokri, A. Nokhodchi, A. Dashbolaghi, D. Hassan-Zadeh, T.Ghafourian and M. Barzegar Jalali, The effect of surfactantson the skin penetration of diazepam, Int. J. Pharm., 228, 99-107 (2001) https://doi.org/10.1016/S0378-5173(01)00805-5
  29. P. Ashton, K.A. Walters, K.R. Brain and J. Hadgraft, Surfactanteffects in percutaneous absoption. I. Effects on the transdrmalflux of methyl nicotmate, Int J. Pharm., 87, 261-264 (1992) https://doi.org/10.1016/0378-5173(92)90251-V
  30. H. Sasaki, M. Kojima, J. Nakamura and J. Shibasaki, Enhancing effect of pyrrolidone derivatives on the transdermal penetration of 5-fluorouracil, triamcinolone acetonide, indomethacin, and flurbiprofen, J. Pharm, Sci., 80, 533-538 (1991) https://doi.org/10.1002/jps.2600800606
  31. H. Okuyama, Y. Ikeda, S. Kasai, K. Imamori, K. Takayama and T. Nagai, Influence of non-ionic surfactants, pH and propylene glycol on percutaneous absorption of piroxicam from cataplasm, Int. J. Pharm., 186, 141-148 (1999) https://doi.org/10.1016/S0378-5173(99)00154-4
  32. S. Santoyo and P. Ygartua, Effect of skin pretreatment with fatty acids on percutaneous absorption and skin retention of piroxicam after its topical application, European J. Pharm.Biopharm., 50, 245-250 (2000) https://doi.org/10.1016/S0939-6411(00)00097-7
  33. H.S. Gwak and I.K. Chun, Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin, Int. J. Pharm., 236, 57-64 (2002) https://doi.org/10.1016/S0378-5173(02)00009-1
  34. M. Yamada and Y. Uda, Enhancement of percutaneous absorption of molsidomine, Chem. Pharm. Bull, 35, 3390-3398 (1987) https://doi.org/10.1248/cpb.35.3390